TrialAntimicrobial agents and chemotherapy2025
Pharmacokinetics, tolerability, and safety of TBI-223, a novel oxazolidinone, in healthy participants.
Antonio Lombardi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it